Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
{{output}}
Background and Objective: Orphan drugs have been a highlight of discussions due to their higher prices than non-orphan drugs. There is currently no European consensus on the method of value assessment for orphan drugs. This study assessed the relationship betw... ...
